The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

EDITORIAL

Two sides to every story: the trade-off between paravalvular leakage and the occurrence of conduction disturbances in transcatheter heart valves

EuroIntervention 2017;13:777-779. DOI: 10.4244/EIJV13I7A113

Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Bonn, Germany


This year, we are celebrating the 15th anniversary of the first transcatheter aortic valve implantation (TAVI). Several randomised trials paved the way for TAVI which has now become the new standard of care for high and intermediate surgical risk patients with non-inferior outcome compared to surgical aortic valve replacement (SAVR)1,2.

Increasing operator experience, better patient selection, and clinical best practice recommendations have helped to optimise procedural results. However, this development would never have been successful without design modifications of the existing devices and the introduction of so-called next-generation transcatheter heart valves (THV)3.

The LOTUS™ aortic valve (Boston ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Do the results of the SYNTAX trial apply to my centre?